Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations

Full text
Author(s):
Silva, Amanda G. [1] ; Krepischi, Ana C. V. [1, 2] ; Pearson, Peter L. [1] ; Hainaut, Pierre [3] ; Rosenberg, Carla [1] ; Achatz, Maria Isabel [4]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, BR-05422970 Sao Paulo - Brazil
[2] AC Camargo Canc Ctr, Int Ctr Res & Training, BR-01508010 Sao Paulo - Brazil
[3] Int Prevent Res Inst, F-69130 Ecully - France
[4] AC Camargo Canc Ctr, Int Ctr Res & Training, Dept Oncogenet, BR-01508010 Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: ORPHANET JOURNAL OF RARE DISEASES; v. 9, APR 28 2014.
Web of Science Citations: 8
Abstract

Background: The Li-Fraumeni syndrome (LFS) is an inherited rare cancer predisposition syndrome characterized by a variety of early-onset tumors. Although germline mutations in the tumor suppressor gene TP53 account for over 50% of the families matching LFS criteria, the lack of TP53 mutation in a significant proportion of LFS families, suggests that other types of inherited alterations must contribute to their cancer susceptibility. Recently, increases in copy number variation (CNV) have been reported in LFS individuals, and are also postulated to contribute to LFS phenotypic variability. Methods: Seventy probands from families fulfilling clinical criteria for either Li-Fraumeni or Li-Fraumeni-like (LFS/LFL) syndromes and negative for TP53 mutations were screened for germline CNVs. Results: We found a significantly increased number of rare CNVs, which were smaller in size and presented higher gene density compared to the control group. These data were similar to the findings we reported previously on a cohort of patients with germline TP53 mutations, showing that LFS/LFL patients, regardless of their TP53 status, also share similar CNV profiles. Conclusion: These results, in conjunction with our previous analyses, suggest that both TP53-negative and positive LFS/LFL patients present a broad spectrum of germline genetic alterations affecting multiple loci, and that the genetic basis of LFS/LFL predisposition or penetrance in many cases might reside in germline transmission of CNVs. (AU)

FAPESP's process: 08/57887-9 - National Institute of Oncogenomics
Grantee:Luiz Paulo Kowalski
Support type: Research Projects - Thematic Grants
FAPESP's process: 09/00898-1 - Submicroscopic genomic imbalances associated with specific congenital abnormalities and mental deficiency phenotypes
Grantee:Carla Rosenberg
Support type: Research Projects - Thematic Grants